Novacyt (NCYT) News Today GBX 39.92 -0.43 (-1.07%) As of 11:46 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock NCYT Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Novacyt Updates on Liquidity Agreement and Voting RightsAugust 1, 2025 | tipranks.comNovacyt Updates on Liquidity Agreement and Share TransactionsJuly 1, 2025 | tipranks.comNovacyt’s AGM Approves Key Resolutions for Strategic GrowthJune 20, 2025 | tipranks.comNovacyt Provides Monthly Liquidity Agreement UpdateMay 2, 2025 | tipranks.comNovacyt Provides March 2025 Liquidity Agreement UpdateApril 1, 2025 | tipranks.comNovacyt unit pleads guilty to health and safety chargesMarch 20, 2025 | investing.comUpdate re. Lab 21 HSE ProsecutionMarch 18, 2025 | actusnews.comNovacyt’s Lab21 Pleads Guilty to Health and Safety ChargesMarch 18, 2025 | tipranks.comNovacyt Updates on Liquidity Agreement and Shareholding StructureMarch 3, 2025 | tipranks.comNovacyt Achieves IVDR Accreditation for Yourgene QST*R Base AssayFebruary 20, 2025 | tipranks.comNovacyt Subsidiary Faces Health and Safety ChargesJanuary 21, 2025 | tipranks.comNovacyt Updates on Liquidity Agreement and Voting RightsJanuary 2, 2025 | tipranks.comNovacyt’s Liquidity Update and Market PresenceDecember 2, 2024 | tipranks.comNovacyt S.A. (NVYTF) Q2 2024 Earnings Call TranscriptSeptember 28, 2024 | seekingalpha.comNovacyt (LON:NCYT) Trading Up 12.8%September 17, 2024 | marketbeat.comNovacyt Share Chat (NCYT)September 16, 2024 | lse.co.ukNovacyt (LON:NCYT) Trading Up 9.9%August 30, 2024 | marketbeat.comCiti Fun 26 Share ChatAugust 28, 2024 | lse.co.ukNovacyt (LON:NCYT) Stock Price Down 14%August 27, 2024 | marketbeat.comMike Lynch's family devastated and in shock, says spokespersonAugust 25, 2024 | lse.co.ukTOP NEWS: UK retail sales rise in July amid triple sports boostAugust 16, 2024 | lse.co.ukLONDON MARKET EARLY CALL: Stocks called up after New York boostAugust 16, 2024 | lse.co.ukNovacyt SA ALNOVMay 21, 2024 | morningstar.comMLong Term Incentive PlanApril 23, 2024 | actusnews.comDHSC Claim update - Pre-Trial ReviewApril 19, 2024 | actusnews.comAstraZeneca increases 2024 dividend by 7%April 12, 2024 | lse.co.ukDirectorate Changes and FY 23 results updateApril 11, 2024 | actusnews.comUpdate on Taiwanese divestmentFebruary 6, 2024 | actusnews.comNovacyt SA NYZJanuary 30, 2024 | morningstar.comMTrading updateJanuary 25, 2024 | actusnews.comReminder to shareholders re. AGM votingSeptember 30, 2023 | actusnews.comCancellation of trading of Yourgene SharesSeptember 11, 2023 | actusnews.comNotice of rescheduled AGMAugust 29, 2023 | actusnews.comYourgene jumps 143% on Novacyt £16.7m knock-out bidJuly 3, 2023 | proactiveinvestors.comChipotle Mexica Share ChatJune 24, 2023 | lse.co.ukNordtelekom Nyr Share ChatJune 14, 2023 | lse.co.ukCalipso Oradea Share ChatJune 12, 2023 | lse.co.ukPublication of Annual Report and AGM votingMay 26, 2023 | actusnews.comNovacyt S.A. ("Novacyt", the "Company" or the "Group"): DHSC Claim Update – Trial Date ListedJanuary 30, 2023 | finance.yahoo.comNovacyt S.A. ("Novacyt", the "Company" or the "Group") Full Year 2022 Trading UpdateJanuary 26, 2023 | finance.yahoo.comNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Non-Executive Director ChangeDecember 7, 2022 | finance.yahoo.comNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Approval of genesig® COVID-19 3G PCR Test in the UK Under CTDA LegislationDecember 6, 2022 | finance.yahoo.comNovacyt S.A. ("Novacyt", the "Company" or the "Group"): Directorate ChangeNovember 10, 2022 | finance.yahoo.comNovacyt gains UK approval for its multiplex PCR test for detection of winter virusesOctober 26, 2022 | proactiveinvestors.comNovacyt approved for COVID and winter viruses PCR testOctober 26, 2022 | proactiveinvestors.comYour three-minute digest - The TimesOctober 10, 2022 | thetimes.co.ukTNovacyt Faces $150 Million Legal Claim For Inconsistent COVID-19 Testing Results In UK - Marketscreener.comOctober 10, 2022 | marketscreener.comMNovacyt subject to legal claim after 'troubling' Covid test results - The TimesOctober 9, 2022 | thetimes.co.ukTOutlook on the High-Resolution Melting Analysis Global Market to 2027 - Featuring Agilent Technologies, Azura Genomics, Illumina and Novacyt Among Others - ResearchAndMarkets.com - Business WireOctober 6, 2022 | businesswire.comNovacyt S.A. 2022 Q2 - Results - Earnings Call Presentation (OTCMKTS:NVYTF) - Seeking AlphaSeptember 30, 2022 | seekingalpha.com Get Novacyt News Delivered to You Automatically Sign up to receive the latest news and ratings for NCYT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NCYT Media Mentions By Week NCYT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NCYT News Sentiment▼0.001.03▲Average Medical News Sentiment NCYT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NCYT Articles This Week▼00▲NCYT Articles Average Week Get the Latest News and Ratings for NCYT and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Novacyt and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Creo Medical Group News Inspiration Healthcare Group News Polarean Imaging News Surgical Innovations Group News MaxCyte News NIOX Group News Smith & Nephew News EKF Diagnostics News Scancell News BATM Advanced Communications News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:NCYT) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novacyt S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Novacyt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access